器官特异性癌症转移机制的见解。
Insights into the mechanism of organ-specific cancer metastasis.
作者信息
Rubin Mark A
机构信息
Institute for Precision Medicine of Weill Cornell Medical College and NewYork-Presbyterian Hospital, New York, New York. Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York. Department of Urology, Weill Cornell Medical College, New York, New York. Meyer Cancer Center of Weill Cornell Medical College and NewYork-Presbyterian Hospital, New York, New York.
出版信息
Cancer Discov. 2014 Nov;4(11):1262-4. doi: 10.1158/2159-8290.CD-14-1075.
Abstract
Lucas and colleagues nominate transmembrane serine protease type II (TMPRSS2) as an important player in the initiation of epithelial-mesenchymal transition (EMT) in prostate cancer. Cancer cells maintain androgen receptor-regulated cytoplasmic TMPRSS2 expression, which facilitates EMT invasion and metastasis in model systems through hepatocyte growth factor and c-MET signaling. In addition to providing a rationale for potentially targeting this organ-specific enabler of metastatic disease progression, this study also highlights the importance of understanding how organ/tissue-specific genes are co-opted in the context of cancer.
摘要
卢卡斯及其同事将II型跨膜丝氨酸蛋白酶（TMPRSS2）确定为前列腺癌上皮-间质转化（EMT）起始过程中的一个重要因素。癌细胞维持雄激素受体调节的细胞质TMPRSS2表达，这在模型系统中通过肝细胞生长因子和c-MET信号促进EMT侵袭和转移。除了为潜在靶向这种转移性疾病进展的器官特异性促成因素提供理论依据外，这项研究还强调了了解器官/组织特异性基因在癌症背景下如何被利用的重要性。
相似文献
1
Insights into the mechanism of organ-specific cancer metastasis.器官特异性癌症转移机制的见解。
Cancer Discov. 2014 Nov;4(11):1262-4. doi: 10.1158/2159-8290.CD-14-1075.
2
The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.雄激素调节的蛋白酶TMPRSS2激活了一个涉及肿瘤微环境成分的蛋白水解级联反应，并促进前列腺癌转移。
Cancer Discov. 2014 Nov;4(11):1310-25. doi: 10.1158/2159-8290.CD-13-1010. Epub 2014 Aug 13.
3
TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.TMPRSS2/ERG 通过 ZEB1/ZEB2 轴在前列腺癌模型中促进上皮间质转化。
PLoS One. 2011;6(7):e21650. doi: 10.1371/journal.pone.0021650. Epub 2011 Jul 1.
4
Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis.雄激素诱导 TMPRSS2 激活组织蛋白酶，促进细胞外基质降解、前列腺癌细胞侵袭、肿瘤生长和转移。
Cancer Res. 2015 Jul 15;75(14):2949-60. doi: 10.1158/0008-5472.CAN-14-3297. Epub 2015 May 27.
5
The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma.雄激素调节的II型丝氨酸蛋白酶TMPRSS2在前列腺腺癌中表达存在差异且定位错误。
J Pathol. 2008 Jun;215(2):118-25. doi: 10.1002/path.2330.
6
TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells.TMPRSS2:ERG基因融合变体在人前列腺癌细胞中诱导转化生长因子-β信号传导及上皮-间质转化。
Oncotarget. 2017 Apr 11;8(15):25115-25130. doi: 10.18632/oncotarget.15931.
7
Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis.抑制 TMPRSS2 表达可降低前列腺癌细胞侵袭和转移。
Oncogene. 2020 Sep;39(37):5950-5963. doi: 10.1038/s41388-020-01413-w. Epub 2020 Aug 10.
8
Androgen Receptor-Activated Enhancers Simultaneously Regulate Oncogene and lncRNA in Prostate Cancer.雄激素受体激活增强子同时调节前列腺癌中的癌基因和长非编码 RNA。
Cells. 2019 Aug 9;8(8):864. doi: 10.3390/cells8080864.
9
TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.TMPRSS4通过诱导Slug和细胞周期蛋白D1来诱导前列腺癌细胞的侵袭和增殖。
Oncotarget. 2016 Aug 2;7(31):50315-50332. doi: 10.18632/oncotarget.10382.
10
The metastasis suppressor CD82/KAI1 represses the TGF-β and Wnt signalings inducing epithelial-to-mesenchymal transition linked to invasiveness of prostate cancer cells.转移抑制因子CD82/KAI1可抑制转化生长因子-β（TGF-β）和Wnt信号通路，这些信号通路可诱导上皮-间质转化，而该转化与前列腺癌细胞的侵袭性相关。
Prostate. 2019 Sep;79(12):1400-1411. doi: 10.1002/pros.23837. Epub 2019 Jun 18.
引用本文的文献
1
Melatonin and Breast Cancer: A Review Article.褪黑素与乳腺癌：一篇综述文章。
Chonnam Med J. 2025 May;61(2):63-74. doi: 10.4068/cmj.2025.61.2.63. Epub 2025 May 23.
2
Intracellular and extracellular factors of colorectal cancer liver metastasis: a pivotal perplex to be fully elucidated.结直肠癌肝转移的细胞内和细胞外因素：一个有待充分阐明的关键难题。
Cancer Cell Int. 2022 Nov 8;22(1):341. doi: 10.1186/s12935-022-02766-w.
3
Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.代谢编程对不同的癌症干细胞的促进作用，推动了胰腺导管腺癌的转移。
Oncogene. 2021 Jan;40(1):215-231. doi: 10.1038/s41388-020-01518-2. Epub 2020 Oct 27.
4
Lentiviral RNA interference-mediated downregulation of Forkhead box M1 expression suppresses growth of oral squamous cell carcinoma .慢病毒RNA干扰介导的叉头框蛋白M1表达下调抑制口腔鳞状细胞癌生长
Oncol Lett. 2019 Jan;17(1):525-531. doi: 10.3892/ol.2018.9536. Epub 2018 Oct 2.
5
TRIM37 promotes epithelial‑mesenchymal transition in colorectal cancer.TRIM37促进结直肠癌中的上皮-间质转化。
Mol Med Rep. 2017 Mar;15(3):1057-1062. doi: 10.3892/mmr.2017.6125. Epub 2017 Jan 16.
6
Melatonin: an inhibitor of breast cancer.褪黑素：一种乳腺癌抑制剂。
Endocr Relat Cancer. 2015 Jun;22(3):R183-204. doi: 10.1530/ERC-15-0030. Epub 2015 Apr 15.
本文引用的文献
1
The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.雄激素调节的蛋白酶TMPRSS2激活了一个涉及肿瘤微环境成分的蛋白水解级联反应，并促进前列腺癌转移。
Cancer Discov. 2014 Nov;4(11):1310-25. doi: 10.1158/2159-8290.CD-13-1010. Epub 2014 Aug 13.
2
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.针对富含纤维母细胞激活蛋白（FAP）的癌相关成纤维细胞中的 CXCL12 进行靶向治疗，与抗 PD-L1 免疫疗法联合应用于胰腺癌。
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20212-7. doi: 10.1073/pnas.1320318110. Epub 2013 Nov 25.
3
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.抗 PD-L1 抗体在晚期癌症患者中的安全性和活性。
N Engl J Med. 2012 Jun 28;366(26):2455-65. doi: 10.1056/NEJMoa1200694. Epub 2012 Jun 2.
4
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.抗 PD-1 抗体在癌症中的安全性、活性和免疫相关性。
N Engl J Med. 2012 Jun 28;366(26):2443-54. doi: 10.1056/NEJMoa1200690. Epub 2012 Jun 2.
5
Tumor immunotherapy directed at PD-1.针对程序性死亡受体1（PD-1）的肿瘤免疫疗法。
N Engl J Med. 2012 Jun 28;366(26):2517-9. doi: 10.1056/NEJMe1205943. Epub 2012 Jun 2.
6
Common gene rearrangements in prostate cancer.前列腺癌的常见基因重排。
J Clin Oncol. 2011 Sep 20;29(27):3659-68. doi: 10.1200/JCO.2011.35.1916. Epub 2011 Aug 22.
7
Hallmarks of cancer: the next generation.癌症的特征：下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
8
Improved survival with ipilimumab in patients with metastatic melanoma.Ipilimumab 改善转移性黑色素瘤患者的生存。
N Engl J Med. 2010 Aug 19;363(8):711-23. doi: 10.1056/NEJMoa1003466. Epub 2010 Jun 5.
9
The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma.雄激素调节的II型丝氨酸蛋白酶TMPRSS2在前列腺腺癌中表达存在差异且定位错误。
J Pathol. 2008 Jun;215(2):118-25. doi: 10.1002/path.2330.
10
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.前列腺癌中TMPRSS2与ETS转录因子基因的反复融合
Science. 2005 Oct 28;310(5748):644-8. doi: 10.1126/science.1117679.
Zotero 插件